1.25 mg semaglutide Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Ozempic 0.25MG + 4mm Needles

Regular use may help support tissue health

For researchers exploring the DAC-modified variant, we also offer CJC-1295 DAC

Scientific References Meloni, A

How long do side effects last after stopping Ozempic?

If you cannot keep down fluids for more than 24 hours, contact your GP or NHS 111 immediately, as persistent vomiting can lead to dehydration and acute kidney injury

It works by simultaneously activating three receptors glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors producing significant reductions in body weight and improvements in metabolic markers